Oura and Counsel Partner Through CMS ACCESS Model to Bring AI-Powered Chronic Care to Medicare Beneficiaries

Smart wearable technology and artificial intelligence are officially stepping into the realm of federal healthcare delivery. In a major development announced today, Oura—the prominent health-tracking ring manufacturer—has expanded its existing partnership with AI-native primary care provider Counsel. This strategic collaboration is taking shape through the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model. The landmark initiative is designed to study how continuous biometric tracking, when paired with physician-led care and artificial intelligence, can be scaled effectively to support aging populations managing chronic health conditions.

Beginning in early 2027, Counsel will roll out its specialized AI-native chronic care services to eligible Medicare beneficiaries across nearly all United States jurisdictions. Crucially, these services will be provided at no out-of-pocket cost to the patients. The program specifically targets some of the most prevalent and burdensome chronic conditions facing older adults today, including hypertension, obesity, hyperlipidemia, and prediabetes. By bridging the gap between passive health monitoring and active clinical intervention, the partnership aims to redefine preventative healthcare and chronic disease management for millions of Americans.

The Evolution of the Oura and Counsel Partnership

To understand the significance of this new federal health integration, one must look back at the foundation built by the two companies. Since May, Oura and Counsel have maintained an ongoing partnership geared toward helping everyday Oura ring members seamlessly transition from reviewing abstract health insights in their mobile application to receiving actionable, real-world clinician guidance.

The mechanism behind this integration relies on bridging continuous data collection with human medical expertise. While the Oura Ring continuously monitors subtle physiological changes—such as resting heart rate, heart rate variability, body temperature, and sleep architecture—Counsel’s platform uses a combination of advanced medical artificial intelligence and on-demand, board-certified physicians to interpret these data streams. When a user observes a shift in their biometric trends, they can leverage Counsel’s ecosystem to make sense of the signals and determine appropriate clinical next steps.

Early results from this commercial collaboration have demonstrated high user satisfaction. In the months following the initial spring integration, Oura members who utilized Counsel’s physician services rated their overall care an impressive 4.6 out of 5 stars. Participants have repeatedly highlighted the exceptional convenience, clarity, and quality of an experience that removes traditional administrative barriers between noticing a health metric and speaking directly with a medical professional. The ACCESS Model initiative takes this proven micro-level framework and scales it to a massive public health infrastructure, bringing these exact benefits directly to the Medicare demographic.

Understanding the CMS ACCESS Model and Federal Objectives

The CMS Innovation Center, officially known as the Center for Medicare and Medicaid Innovation (CMMI), was established under the Affordable Care Act to test innovative payment and service delivery models designed to reduce program expenditures while preserving or enhancing the quality of care. The Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model represents the latest federal effort to address the surging costs and logistical strains associated with managing chronic illnesses in the United States.

Chronic diseases account for the vast majority of the nation’s healthcare expenditures, with older adults aged 65 and older representing a disproportionate share of this utilization. Conditions like hypertension and obesity are foundational drivers of more severe cardiovascular events, kidney disease, and metabolic disorders. By partnering with agile health-tech firms like Oura and Counsel, CMS is actively signaling an openness to digital health interventions, remote patient monitoring, and artificial intelligence as viable pathways to curb disease progression.

Through the ACCESS Model framework, Oura and Counsel will deploy their combined technologies to study outcomes at scale. Federal regulators and independent researchers will closely evaluate whether integrating continuous wearable biometrics into routine Medicare workflows can lead to better clinical outcomes, improved medication adherence, earlier interventions, and ultimately, a reduction in costly emergency room visits and hospitalizations.

Demographic Realities: Why Older Adults and Wearables Are a Powerful Match

A common misconception in the technology sector is that advanced wearables are exclusively adopted by younger, tech-savvy demographics. However, internal data from Oura reveals a starkly different reality. Members aged 65 and older consistently rank among the most engaged age groups across the entire platform, displaying exceptionally high daily application engagement rates and meticulous tracking habits.

This high level of engagement among older adults provides a fertile ground for public health initiatives. Furthermore, epidemiological data within Oura’s ecosystem highlights the urgent need for targeted interventions in this cohort: approximately 20% of Oura members aged 65 and older present with a Body Mass Index (BMI) of 30 or higher, placing them squarely in the category of obesity. This specific data point underscores the precise alignment between Oura’s core user base and the clinical targets of the CMS ACCESS Model—obesity, hypertension, hyperlipidemia, and prediabetes.

The integration of continuous data streams solves a historical limitation of traditional primary care: the reliance on sporadic, point-in-time measurements taken during annual physical examinations or episodic doctor visits. By combining the continuous accuracy of Oura’s hardware with the on-demand, personalized care infrastructure of Counsel, elderly patients receive a level of continuous medical visibility that traditional healthcare systems have historically struggled to provide.

Leadership Perspectives on the Collaboration

Industry leaders from both participating organizations have emphasized the transformative potential of this federal collaboration. Dr. Ricky Bloomfield, Chief Medical Officer at Oura, highlighted the strategic leap from consumer wellness to regulated clinical intervention.

"Earlier in the year, we partnered with Counsel to help Oura Members move from health insights to clinical action," stated Dr. Bloomfield. "The ACCESS program gives us the opportunity to study that model at scale, and to better understand how continuous biometric data, combined with physician-led care, can support Medicare beneficiaries managing hypertension, obesity, and other early cardio-kidney-metabolic conditions."

From Counsel’s perspective, the collaboration validates the core premise of its AI-native healthcare delivery model. By pairing sophisticated machine learning models with human physicians, Counsel can handle routine triage, data synthesis, and personalized patient communication efficiently, allowing doctors to focus their time and expertise on direct patient care and complex medical decision-making.

Logistics and Enrollment: What Medicare Beneficiaries Need to Know

As the health tech community looks ahead to the formal rollout, both companies have outlined clear pathways for patient onboarding. When the program launches in early 2027, Oura will actively support Counsel’s ACCESS initiative by utilizing the Oura App interface to inform and connect interested members with Counsel’s care teams.

It is important to note that clinical eligibility will be independently verified by Counsel, which will also manage all aspects of patient enrollment, regulatory compliance, and clinical care delivery. Comprehensive details regarding exact eligibility criteria, onboarding workflows, and specific regional rollouts will be communicated directly to Oura members via the mobile application as the 2027 launch date approaches.

Broader Implications for the Future of Digital Health

The integration of Oura and Counsel into the CMS ACCESS Model marks a watershed moment for the digital health and wearable technology industries. For over a decade, consumer-grade health devices have occupied a unique space, operating largely parallel to the formal healthcare system. While millions of consumers relied on smart rings, smartwatches, and fitness bands to track their sleep, activity, and vital signs, physicians rarely had direct access to this continuous data during clinical encounters.

This federal initiative signals a regulatory and systemic shift toward valuing continuous real-world evidence generated by consumer hardware. If the ACCESS Model proves successful in demonstrating improved health outcomes and cost efficiencies for Medicare beneficiaries, it could establish a blueprint for future public and private insurance reimbursements involving wearable technology.

By proving that artificial intelligence, consumer-grade biometric tracking, and virtual primary care can successfully converge to manage complex chronic conditions in vulnerable populations, Oura and Counsel are helping to pioneer a new era of proactive, data-driven medicine. For the millions of aging Americans navigating the complexities of chronic disease management, the coming years promise a healthcare experience that is increasingly personalized, continuous, and responsive to the subtle signals of the human body.